- Page 3/3
- Next Page
The pharma sector. Any picks? Pharma's problem is the US election cycle when candidates always bash big pharma. But these stocks are not expensive now, like JNJ which boasts 3 divisions (consumer, medical devices and pharma); and Novo Nordisk, which offers a diabetes pill and obesity pill. Buy a small position now as well as when they pull back during the election campaign, and certainly after the election. NVO increases its dividend perennially. The Dems and Republicans are equally critical of pharma.
Buy now ahead of the holiday shopping season? It's cheap, trading at 10x earnings. They have 3 issues: they're losing revenues from losing Amazon; the TNT Express acquisition has been really difficult to absorb; and they are going to 7 days of ground delivery which raises their costs. That said, you can wait and buy FedEx when it's cheaper.
They have the best content to compete with Netflix and are priced well. There may be some execution risk after buying Fox, but their amusement parks still make up a big chunk of revenues. Also, their brand is unmatched. (Analysts’ price target is $153.71)
The pharma sector. Any picks? Pharma's problem is the US election cycle when candidates always bash big pharma. But these stocks are not expensive now, like JNJ which boasts 3 divisions (consumer, medical devices and pharma); and Novo Nordisk, which offers a diabetes pill and obesity pill. Buy a small position now as well as when they pull back during the election campaign, and certainly after the election. NVO increases its dividend perennially. The Dems and Republicans are equally critical of pharma.
The largest private equity company in the world. BX has raised a ton of money lately, but the trouble is how do they put this money to work? Low interest rates help, because they leverage a lot. They are in real estate, and loans, not just private equity--so well-diversified. Problem is, BX now competes heavily in private markets (with BAM-N, for example), an area which enjoys higher rates of return. There's a lot of money chasing fewer deals. However, BX is an incredibly well-run company.